BioInvent International AB

Start Date End Date Funded Value Relevance

CSV

25 50 100

Oct 17 - Sep 21

Engineering chimeric antigen receptor T Cells against human LILRB3 for treatment of acute myeloid leukaemia (AML)

MRC award to University of Southampton

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}